Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $183,028 - $218,279
4,578 New
4,578 $208,000
Q3 2022

Nov 15, 2022

SELL
$53.86 - $66.8 $14,488 - $17,969
-269 Reduced 5.55%
4,578 $247,000
Q2 2022

Aug 11, 2022

SELL
$63.83 - $80.0 $8,553 - $10,720
-134 Reduced 2.69%
4,847 $311,000
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $30,739 - $35,780
-400 Reduced 7.43%
4,981 $386,000
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $4,697 - $5,492
63 Added 1.18%
5,381 $462,000
Q4 2020

Jan 27, 2021

BUY
$75.39 - $82.36 $46,364 - $50,651
615 Added 13.08%
5,318 $427,000
Q3 2020

Nov 12, 2020

BUY
$78.33 - $90.73 $9,791 - $11,341
125 Added 2.73%
4,703 $378,000
Q3 2018

Oct 12, 2018

SELL
$70.71 - $77.75 $107,620 - $118,335
-1,522 Reduced 24.95%
4,578 $353,000
Q2 2018

Jul 24, 2018

SELL
$63.43 - $75.41 $50,744 - $60,328
-800 Reduced 11.59%
6,100 $450,000
Q1 2018

May 08, 2018

SELL
$62.56 - $72.26 $3,315 - $3,829
-53 Reduced 0.76%
6,900 $449,000
Q4 2017

Feb 13, 2018

BUY
$61.45 - $66.05 $3,256 - $3,500
53 Added 0.77%
6,953 $449,000
Q3 2017

Nov 13, 2017

BUY
$59.5 - $64.61 $410,550 - $445,809
6,900
6,900 $0

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Douglass Winthrop Advisors, LLC Portfolio

Follow Douglass Winthrop Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.